Adagio Medical Holdings, Inc., a developmental stage medical device company, focuses on the development and commercialization of ablation technologies for the treatment of cardiac arrhythmias. It offers treatment for cardiac arrhythmias, including atrial fibrillation, atrial flutter, and ventricular tachycardia. The company's product portfolio includes iCLAS atrial ultra-low temperature cryoablation (ULTC) catheter and accessories; vCLAS ventricular ULTC catheter; and Cryopulse atrial pulsed-field cryoablation catheter and accessories. Adagio Medical Holdings, Inc. was founded in 2011 and is headquartered in Laguna Hills, California. Show more
Location: 26051 Merit Circle, Laguna Hills, CA, 92653, United States | Website: https://adagiomedical.com | Industry: Medical Devices | Sector: Healthcare
Market Cap
31.69M
52 Wk Range
$0.63 - $4.20
Previous Close
$2.06
Open
$2.09
Volume
136,448
Day Range
$2.06 - $2.39
Enterprise Value
40.5M
Cash
8.20M
Avg Qtr Burn
-6.911M
Insider Ownership
0.29%
Institutional Own.
87.46%
Qtr Updated
06/30/25
Drug Pipeline
Powered by

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.
Drug & Indication | Stage & Event | Catalyst Date |
---|